Nagarajan K. Chemo-radiotherapy induced oral mucositis during IMRT for head and neck cancer - An assessment. Med Oral Patol Oral Cir Bucal. 2015 May 1;20 (3):e273-7.

 

 

doi:10.4317/medoral.20126

http://dx.doi.org/doi:10.4317/medoral.20126

 

 

1. Kumari R, Chaugule A, Goyal PK. Karyoanomalic frequency during radiation therapy. J Cancer Res Ther. 2005;1:187-90.
http://dx.doi.org/10.4103/0973-1482.19604

 

2. Umiker W, Lampe I, Rapp R, Latourette H, Boblitt D. Irradiation effects on malignant cells in smears from oral cancers; a preliminary report. Cancer. 1959;12:614-9.
http://dx.doi.org/10.1002/1097-0142(195905/06)12:3<614::AID-CNCR2820120322>3.0.CO;2-X

 

3. Trotti A. Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys. 2000;47:1-12.
http://dx.doi.org/10.1016/S0360-3016(99)00558-1

 

4. Parulekar W, Mackenzie R, Bjarnason G, Jordan RC. Scoring oral mucositis. Oral Oncol. 1998;34:63-71.
http://dx.doi.org/10.1016/S1368-8375(97)00065-1

 

5. Spijkervet FK, van Saene HK, Panders AK, Vermey A, Mehta DM. Scoring irradiation mucositis in head and neck cancer patients. J Oral Pathol Med. 1989;18:167-71.
http://dx.doi.org/10.1111/j.1600-0714.1989.tb00756.x

 

6. Sonis ST. Mucositis as a biological process: a new hypothesis for thedevelopment of chemotherapy-induced stomatotoxicity. Oral Oncol. 1998;34:39-43.
http://dx.doi.org/10.1016/S1368-8375(97)00053-5

 

7. de Mendona RM, de Araœjo M, Levy CE, Morari J, Silva RA, Yunes JA, et al. Prospective evaluation of HSV, Candida species and oral bacteria on the severity of oral mucositis in pediatric acute lymphoblastic leukemia. Support Care Cancer. 2012;20:1101-7.
http://dx.doi.org/10.1007/s00520-011-1190-0

 

8. Bensadoun RJ, MagnŽ N, Marcy PY, Demard F. Chemotherapy- and radiotherapy-induced mucositis in head and neck cancer patients: new trends in pathophysiology, prevention and treatment. Eur Arch Otorhinolaryngol. 2001;258:481-7.
http://dx.doi.org/10.1007/s004050100368

 

9. Phillips TL, Fu KK. Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues. Cancer. 1976;37:1186-200.
http://dx.doi.org/10.1002/1097-0142(197602)37:2+<1186::AID-CNCR2820370830>3.0.CO;2-V

 

10. Wymenga AN, van der Graaf WT, Spijkervet FL, Timens W, Timmer-Bosscha H, Sluiter WJ, et al. A new in vitro assay for quantitation of chemotherapy-induced mucositis. Br J Cancer. 1997;76:1062-6.
http://dx.doi.org/10.1038/bjc.1997.508

 

11. Sonis ST. Management of Oral Mucositis. Cancer. 2004;100:1995-2025.
http://dx.doi.org/10.1002/cncr.20162

 

12. Ahmed HG, Elemirri DA. Assessment of oral cytological changes associated with exposure to chemotherapy and/or radiotherapy. Cytojournal. 2009;6:8.
http://dx.doi.org/10.4103/1742-6413.51332

 

13. Toth BB, Martin JW, Fleming TJ. Oral complications associated with cancer therapy. An M. D. Anderson Cancer Center experience. Journal of clinical periodontology. 1990:17:508-15.
http://dx.doi.org/10.1111/j.1365-2710.1992.tb01225.x

 

14. Kšstler WJ, Hejna M, Wenzel C, Zielinski CC. Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA: a cancer journal for clinicians. 2001:51:290-315.
http://dx.doi.org/10.3322/canjclin.51.5.290

 

15. Sonis ST, Eilers JP, Epstein JB, LeVeque FG, Liggett WH, Mulagha MT, et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group. Cancer. 1999;85:2103-13.
http://dx.doi.org/10.1002/(SICI)1097-0142(19990515)85:10<2103::AID-CNCR2>3.0.CO;2-0

 

16. Sonis ST, Woods PD, White BA. Oral complications of cancer therapies. Pretreatment oral assessment. NCI Monogr. 1990:29-32.

 

17. Harris DJ. Cancer treatment-induced mucositis pain: strategies for assessment and management. Ther Clin Risk Manag. 2006;2:251-8.
http://dx.doi.org/10.2147/tcrm.2006.2.3.251

 

18. Stokman MA, Spijkervet FK, Wymenga AN, Burlage FR, Timens W, Roodenburg JL, et al. Quantification of oral mucositis due to radiotherapy by determining viability and maturation of epithelial cells. J Oral Pathol Med. 2002;31:153-7.
http://dx.doi.org/10.1034/j.1600-0714.2002.310305.x

 

19. Scully C, Epstein J, Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis. Head & neck. 2003:25:1057-70.
http://dx.doi.org/10.1002/hed.10318

 

20. Archibald D, Lockhart PB, Sonis ST, Ervin TJ, Fallon BG, Miller D, et al. Oral complications of multimodality therapy for advanced squamous cell carcinoma of head and neck. Oral Surg Oral Med Oral Pathol. 1986;61:139-41.
http://dx.doi.org/10.1016/0030-4220(86)90174-X

 

21. Rosenthal DI. Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes. J Support Oncol. 2007:5:23-31.